Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
TLDR
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results, however, no differences have been found in terms of impact factor.Abstract:
Objectives
Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications.
Methods and Findings
All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61–2·56) for studies with results classified as positive and 3·21 years (IC95 2·69–3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55–2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141–28·409) and negative result studies (median 8·266, interquartile range: 4·135–17·157).
Conclusions
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.read more
Citations
More filters
Journal ArticleDOI
Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
Cláudia Silva,André M. Travessa,André M. Travessa,Raquel Bouça-Machado,Daniel Caldeira,Daniel Caldeira,Joaquim J. Ferreira,Joaquim J. Ferreira +7 more
TL;DR: Although a large number of trials on exercise are registered in international portals, the quality of reporting remains suboptimal and only a quarter of trials have their results published in scientific journals, which compromise the interpretation of study results.
Posted ContentDOI
Propionic acid enhances the virulence of Crohn's disease-associated adherent-invasive Escherichia coli
Michael J. Ormsby,Síle A. Johnson,Lynsey M. Meikle,Robert J. Goldstone,Anne McIntosh,Hannah M. Wessel,Heather Hulme,Ceilidh C. McConnachie,James P. R. Connolly,Andrew J. Roe,Eamonn Fitzgerald,Konstantinos Gerasimidis,Douglas J. Morrison,David Smith,Daniel M. Wall +14 more
TL;DR: In this paper, the authors examined the effect of short chain fatty acids (SCFA) on the pathogenicity of the Crohn's disease-associated microbe, adherent-invasive Escherichia coli (AIEC).
Posted ContentDOI
No general relationship between mass and temperature in endotherm species
TL;DR: The results suggest that Bergmann's rule is not general and temperature is not a dominant driver of biogeographic variation in mass, which weakens the justification for the hypothesis that global warming could result in widespread decreases in body size.
Posted ContentDOI
Combining Focused Identification of Germplasm and Core Collection Strategies to Identify Genebank Accessions for Central European Soybean Breeding
Max Haupt,Karl Schmid +1 more
TL;DR: A Focused Identification of Germplasm Strategy with core collection methodology is combined to select soybean (Glycine max) germplasm for Central European breeding from a collection of >17,000 accessions, demonstrating the potential of diversity panels for studying environmental adaptation.
Posted ContentDOI
Perfluoroalkyl substances are increased in patients with late-onset ulcerative colitis and induce intestinal barrier defects ex vivo in murine intestinal tissue
Frida Fart,Samira Salihovic,Aidan McGlinchey,Mélanie G. Gareau,Matej Orešič,Matej Orešič,Jonas Halfvarson,Tuulia Hyötyläinen,Ida Schoultz +8 more
TL;DR: The results demonstrate that perfluoroalkyl substances levels are increased in patients with late-onset ulcerative colitis and might contribute to the disease by inducing a dysfunctional intestinal barrier or indirectly by interfering with the bile acid metabolism and thereby alter the intestinal barrier function.
References
More filters
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and should provide the reader with the ability to make informed judgments regarding the internal and external validity of the trial.
Journal ArticleDOI
Publication bias in clinical research
TL;DR: The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.
Journal ArticleDOI
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
TL;DR: The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.